In conclusion, we demonstrated that patients with RA have a variety of immune cell disorders, such as CD4+T, CD19+B, Th17, Treg, and ILC subsets, but these immune cell dysregulations may not be related to RF and ACPA autoantibodies. The gene discussed is CD19; the disease is rheumatoid arthritis.